These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6285818)
1. Efficiency and selectivity of (E)-5-(2-bromovinyl)-2'-deoxyuridine and some other 5-substituted 2'-deoxypyrimidine nucleosides as anti-herpes agents. Reefschläger J; Brwolff D; Bärwolff D; Langen P; Rosenthal HA Antiviral Res; 1982 May; 2(1-2):41-52. PubMed ID: 6285818 [TBL] [Abstract][Full Text] [Related]
2. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines. Reefschläger J; Bärwolff D; Herrmann G; Langen P Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491 [TBL] [Abstract][Full Text] [Related]
3. Differential antiherpes activity of the (E)-and (Z)-isomers of 5-(2-fluorovinyl)-2'-deoxyuridine (FVUdR). Reefschläger J; Bärwolff D; Langen P Acta Virol; 1984 Jul; 28(4):282-6. PubMed ID: 6148852 [TBL] [Abstract][Full Text] [Related]
4. Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines. Reefschläger J; Herrmann G; Bärwolff D; Schwarz B; Cech D; Langen P Antiviral Res; 1983 Sep; 3(3):175-87. PubMed ID: 6316849 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice. Reefschläger J; Wutzler P; Thiel KD; Bärwolff D; Langen P; Sprössig M; Rosenthal HA Antiviral Res; 1982 Oct; 2(5):255-65. PubMed ID: 6295273 [TBL] [Abstract][Full Text] [Related]
6. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments]. Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299 [TBL] [Abstract][Full Text] [Related]
7. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents. Kumar R Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191 [TBL] [Abstract][Full Text] [Related]
10. Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity. Veerisetty V; Balasubramaniam NK; Gentry GA Acta Virol; 1990 Dec; 34(6):568-73. PubMed ID: 1983184 [TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir. Reefschläger J; Wutzler P; Thiel KD; Herrmann G Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858 [TBL] [Abstract][Full Text] [Related]
12. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors. Aduma PJ; Gupta SV; De Clercq E Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR). Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622 [TBL] [Abstract][Full Text] [Related]
14. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds. Schinazi RF; Nahmias AJ Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731 [TBL] [Abstract][Full Text] [Related]
15. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. De Clercq E; Descamps J; De Somer P; Barr PJ; Jones AS; Walker RT Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2947-51. PubMed ID: 223163 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs. De Clercq E; Walker RT Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses. Ayisi NK; Gupta SV; Babiuk LA Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of herpes simplex virus types 1 and 2 by sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Mayo DR J Clin Microbiol; 1982 Apr; 15(4):733-6. PubMed ID: 6279696 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine. Jones AS; Rahim SG; Walker RT; De Clercq E J Med Chem; 1981 Jun; 24(6):759-60. PubMed ID: 6265638 [TBL] [Abstract][Full Text] [Related]
20. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells. Suzutani T; Machida H; Sakuma T Antimicrob Agents Chemother; 1988 Jul; 32(7):1046-52. PubMed ID: 2847637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]